the effect of Melatonin on sphincter disorder in multiple sclerosis

the effect of Melatonin on sphincter disorder(urinary symptoms) in multiple sclerosis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017022620258N34

Enrollment

Registered

2017-03-09

Start date

2015-06-09

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: Intervention group:We prescribe 3 milligram Melatonin and Interfron for 8 weeks for 30 patients. Intervention 2: Control group:We prescribe placebo and Interfron for 8 weeks for 30 pat

Treatment - Drugs

Intervention group:We prescribe 3 milligram Melatonin and Interfron for 8 weeks for 30 patients.

Control group:We prescribe placebo and Interfron for 8 weeks for 30 patients.

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: multiple sclerosis with Mc.donald score; 18 to 50 years; EDSS 0 to 5/5; multiple sclerosis with IFN-B Exclusion criteria: pregnancy; patients with acute attack in 3 months ago; Lack of routine monitoring of patients

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Urinary ?disorder. Timepoint: before and after 8 week. Method of measurement: standard questionnaire urodynamic.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Fardin Faraji

Arak University of Medical Sciences

faraji@arakmu.ac.ir+98 86 3222 2003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026